Also, Cav-1 is demonstrated to restrain the conversion of low glycosylation CD147 to high glycosylation (Tang et al., 2004), inhibiting MMP induction and ECM degradation and acting as tumor suppressor because high glycosylation CD147 can stimulate the induction of MMP (Figure 4). The gene discussed is CAV1; the disease is neoplasm.